BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
39.00
0.00 (0.00%)
May 9, 2025, 3:30 PM JST

TYO:4594 Balance Sheet

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2018 FY 2017
Period Ending
Dec '18 Mar '18 Mar '17
Cash & Equivalents
5,2346,5284,950
Cash & Short-Term Investments
5,2346,5284,950
Cash Growth
32.77%31.88%-
Receivables
97754
Inventory
-2742
Other Current Assets
303268193
Total Current Assets
5,5466,9005,239
Property, Plant & Equipment
95266115
Long-Term Investments
485539
Other Intangible Assets
-1313
Other Long-Term Assets
112
Total Assets
5,6907,2355,408
Accounts Payable
29822
Current Income Taxes Payable
82198113
Other Current Liabilities
202326
Total Current Liabilities
131229161
Long-Term Deferred Tax Liabilities
444
Other Long-Term Liabilities
242118
Total Liabilities
186285208
Common Stock
5,4275,4193,774
Additional Paid-In Capital
5,4045,4033,757
Retained Earnings
-5,399-3,929-2,352
Comprehensive Income & Other
725720
Total Common Equity
5,5046,9505,199
Minority Interest
--1
Shareholders' Equity
5,5046,9505,200
Total Liabilities & Equity
5,6907,2355,408
Net Cash (Debt)
5,2346,5284,950
Net Cash Growth
32.77%31.88%-
Net Cash Per Share
125.57170.73145.52
Filing Date Shares Outstanding
41.9741.8637.22
Total Common Shares Outstanding
41.9741.8437.22
Working Capital
5,4156,6715,078
Book Value Per Share
131.15166.13139.69
Tangible Book Value
5,5046,9375,186
Tangible Book Value Per Share
131.15165.82139.34
Updated Feb 14, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.